1995; Madine et al., 2000) . Soluble are abundant in interphase nuclei during the whole cell cycle (Forsburg, 2004) . Insoluble are typically present in G1 (licensed) and replicating (S-phase) nuclei. It is suggested that Mcm2-7 proteins bind as a heterohexamer to the region of DNA where the ORC complex binds. The insoluble (DNA-associated) are gradually detached from the chromatin while the process of DNA replication proceeds and in the G2 nuclei the insoluble form of these proteins are no longer detectable (Todorov et al., 1995; Dimitrova et al., 1999; Prasanth et al., 2004) .
Nuclei of ovarian oocytes of the mouse are arrested in the diplotene of first meiotic prophase. They are thought to be in a prolonged G2 phase, since the last round of DNA replication occurred in the embryonic gonad, before the entry of the germ cells into meiosis (Peters et al., 1962; Lima-de-Faria and Borum, 1962) . Prolonged arrest in G2 implies that, the DNA replication must be repressed until after the completion of cell division (two meiotic divisions in mouse oocytes). Thus, the chromatin of the nucleus of mouse G2 oocyte should be in the unlicensed state and the chromatin licensing (building the pre-RC complexes) should occur with the triggering of the first embryonic cell cycle (after oocyte fertilization or artificial activation). To understand how the competence for the DNA replication is built in the activated oocyte it is necessary to know whether the proteins of pre-RC are available in oocytes. The Mcm2-7 proteins have been recently found in the fully-grown oocytes of Xenopus (Whitmire et al., 2002 , Lemaître et al., 2002 . The Mcm2 protein was found in the fully-grown oocytes of mouse and Drosophila (Lemaître et al., 2004) and in the primary human oocytes (Eward et al., 2004) . The latter studies demonstrated the presence of total Mcm2 protein without discrimination between its two (insoluble and soluble) forms.
In the present paper we followed the distribution of Mcm2, 6 and 7 in resting, growing and fully-grown mouse ovarian oocytes as well as in maturing oocytes and parthenogenetic one-cell embryo. We show that the soluble forms of these three proteins are abundant in the nuclei of all types of ovarian oocytes studied, i.e. far in advance of the first embryonic S-phase. We document also the presence of insoluble form of Mcm2 and Mcm7, but 
Results

Localization of insoluble forms of Mcm2, 6 and 7 in primordial and growing oocytes
Primordial oocytes
The nuclei of the primordial or resting oocytes (diameter 12-14 µm) obtained from the ovaries of 2-3-days-old newborn mice, as well as the nuclei of slightly larger oocytes (diameter ca 20 µm, 5 days post partum (dpp)) contained decondensed chromatin and stained homogenously with the chromomycin except of the area corresponding to the nucleolus, which remained unstained ( A'' Mcm2, was visible as the distinct fluorescent spots (Fig.1A' ) and insoluble Mcm7 formed irregular patches (Fig. 1B' ) distributed randomly in the nucleus. In contrast to Mcm2 and 7 the immunostaining for Mcm6 protein showed only faint diffuse signal (Fig. 1C') .
Growing oocytes
Mouse oocytes from the middle of growth period (from females 10-12 dpp) were 50-60µm in diameter. Their chromatin was stained with two different chromatin dyes: Hoechst dye and chromomycin (Hoechst dye binds to DNA fragments rich in A-T pairs, while chromomycin binds fragments of DNA containing at least three G-C pairs). Staining with Hoechst showed that the majority of chromatin of 10-12 dpp oocytes was highly decondensed, with the exception of several dense patches ( Fig. 2A ; arrows) often located in the proximity of a large nucleolus. After staining with chromomycin, the chromatin was visible as a uniformly stained reticulum (Fig. 1 D,E,F ; arrows indicate the nucleoli). The insoluble form of Mcm2 protein was visible as strongly fluorescent, randomly distributed globules, varying in number and size (Figs. 1D', 2A'). These globules did not co-localize with the dense chromatin patches visualized by Hoechst staining ( Fig. 2A'' ). The insoluble Mcm7 protein formed several small patches less intensely stained than the Mcm2 globules, often localized in the proximity of the nucleolus (Fig.  1E' ). The number of patches oscillated from 2 to 13 (5 in an average). The insoluble Mcm6 protein never formed granules or patches. Very faint, diffuse signal, slightly above the background staining of the cytoplasm was detected in the nucleoplasm (Fig. 1F') .
Localization of insoluble forms of Mcm2, 6 and 7 in fullygrown oocytes
Fully-grown ovarian oocytes (diameter > 80 µm) obtained from sexually mature females belong into two main classes depending on the morphology of the nucleus: 1. oocytes with diffuse chromatin and usually centrally located nucleolus not surrounded by the chromatin rim (NSN oocytes) and 2. oocytes with more compact chromatin and eccentrically located nucleolus surrounded by the rim of condensed chromatin (SN oocytes) (Debey et al., 1993; Zuccotti et al., 1995) . A spectrum of transitory stages between NSN and SN oocytes were also found.
The insoluble form of Mcm2 protein was present in both types of fully-grown oocytes, but its distribution in the nuclei of NSN and SN oocytes differed significantly. NSN oocytes displayed nuclear pattern of Mcm2 distribution similar to that observed in 10-12 dpp oocytes (Fig. 3A' ). The distribution of insoluble Mcm2 protein in SN oocytes was dramatically different. In these oocytes chromatin gradually condenses beginning from the region surrounding the nucleolus (for details see Calarco et al., 1972; Debey et al., 1993; Zuccotti et al., 1995) . At the early step of this process most of the chromatin forms a dense mass around the nucleolus, but The globules of Mcm2 are distributed randomly in the nucleus. Merger (A") of (A and A') shows that Mcm2 globules do not co-localize with the patches of highly condensed chromatin. A'' 286 Swiech et al. some portion of less condensed chromatin remains outside the mass (Fig. 3 B,C) . The insoluble form of Mcm2 formed large aggregates (in the proximity of the nucleolus) and smaller spots dispersed within the nucleus (Fig. 3 B' ,C'). The nucleoplasm remained unstained. In a more advanced stage of chromatin condensation, the majority of the chromatin was visible as a rim around the nucleolus (Fig. 3 D,E ) and the aggregates of insoluble Mcm2 protein were irregular in shape. In small, dispersed fragments of chromatin, located outside the chromatin rim the level of Mcm2 was low (Fig. 3D') . In some SN oocytes the aggregates of insoluble Mcm2 were no longer visible and the overall fluorescence of the nuclei was very faint (Fig. 3E') . The insoluble Mcm6 protein was never observed -neither in the NSN, nor in the SN oocytes (Fig. 4A') . The distribution of insoluble Mcm7 protein in NSN and SN oocytes differed, but these differences were less spectacular than in the case of Mcm2. In NSN oocytes Mcm7 protein formed small patches of rather low fluorescence (Fig. 4B') . In SN oocytes, the insoluble form of Mcm7 was never detected, irrespectively of the stage of chromatin condensation (Fig. 4C') .
To verify whether the granules or aggregates of Mcm2 were bound to the chromatin, the fully-grown NSN and SN oocytes were treated with DNase I during the extraction procedure. After 10 min. treatment of NSN oocytes, 3-4 single granules of insoluble form of Mcm2 protein (usually smaller and less intensively stained than in control oocytes) were observed (Supplementary material, Fig. S3 B',C'). In SN oocytes submitted to the same treatment, Mcm2 formed dispersed irregular patches (Fig. S3 D' ). 30 minutes treatment with DNase I removed the remnants of the chromatin and resulted in the loss of Mcm2 staining in both types of oocytes (Fig.  S3E') . We asked whether reorganization of insoluble form of Mcm2 and Mcm7 observed in fully-grown oocytes might be linked to changes, which are known to occur during transition from NSN to SN type of oocytes and involve chromatin remodeling and silencing of RNA synthesis (Bouniol-Baly et al., 1999; De La Fuente and Eppig, 2001) . To answer this question we have analyzed the distribution of insoluble Mcm2 and Mcm7 proteins in growing oocytes, in which transcription has been inhibited by α-amanitin.
In control growing oocytes, cultured for 20-24 h, the chromatin was dispersed and filled the entire area of the nucleus, similarly as it was observed in freshly isolated growing oocytes. In contrast, the configuration of chromatin in oocytes cultured for the same period of time in the presence of'α-amanitin was markedly changed. Chromatin condensed and often formed a dense mass surrounding the nucleolus (Fig. 5 A,D) . These nuclei resembled the nuclei 
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pronucleus of one-cell parthenogenetic embryo. Artificial activation of ovulated mouse oocytes triggers resumption of meiosis (i.e. completion of the second meiotic division). After extrusion of the second polar body, activated eggs enter the first embryonic cell cycle with typical G1, S, G2 and M phases. In our experiment (see Materials and Methods) oocytes activated artificially formed haploid nucleus (female pronucleus) about 3 1/2 -4 h after activation (a.a.), entered S phase about 5-6 h a.a. and completed replication at 13 h a.a. First embryonic mitoses usually occurred between 16 and 18 h a.a. in a given group of parthenogenetic embryos.
To detect the total (soluble and insoluble) Mcm2 protein the immunostaining with anti-Mcm2 antibody was performed on onecell embryos not submitted to extraction procedure. The soluble form of Mcm2 was abundant in the pronuclei of one-cell embryos and masked the presence of the insoluble Mcm2. Strong, uniform fluorescence was observed over the pronuclei independently of the phase of cell cycle (compare: pronuclei in G1 (Fig. 7A' ) and in G2 (Fig. 8A') ). Mcm2-positive dots, similar to observed in maturing oocytes and probably representing the insoluble form of Mcm2 of fully-grown SN type oocytes. The less condensed nuclei were more similar to transitory stages between NSN and SN type (Fig. 5 B, C) . Control oocytes intensively synthesized RNA. In contrast, culture in the presence of α-amanitin resulted in inhibition of transcription.
In control oocytes the distribution of insoluble form of Mcm 2 and Mcm7 was identical with that observed in freshly isolated growing oocytes (see Fig.1 D' ,E'). In oocytes treated with α-amanitin the insoluble form of Mcm2 underwent pronounced rearrangement. The most striking was the appearance of 2 or 3 large aggregates of Mcm2 ( Fig. 5 A' ,B'; arrows; compare with Fig. 1D') . The insoluble form of Mcm7 was also rearranged. Either 3 -5 faintly stained and highly blurred patches (resembling the patches of insoluble Mcm7 detected in fully-grown NSN oocytes) were observed ( Fig. 5 C' ,D'), or this protein form was absent (like in SN oocytes).
Localization of the insoluble form of Mcm2 during meiotic maturation
We have shown that the only protein stored in the nuclei of fullygrown SN oocytes is the insoluble Mcm2. In some oocytes (likely preparing for meiotic maturation) this protein was partly eliminated from the nucleus (see Fig. 3E '). We focused our attention on further fates of insoluble Mcm2 in maturing oocytes. The earliest changes in the permeability of the nuclear envelope, preceding the nuclear envelope breakdown Ellenberg, 2003, Lénárt et al., 2003, Kozdrój and Borsuk, unpublished data) were followed after intracytoplasmic injection of dextran conjugated with fluorescein (MW 70 000). Entrance of dextran from the cytoplasmic to the nuclear compartment marked the beginning of the maturation process. In the fully-grown SN mouse oocytes germinal vesicle breakdown (GVBD) was usually observed 10-20 min. after the penetration of dextran into the nucleus. In such oocytes insoluble Mcm2 protein never formed large aggregates. Usually smaller clusters, expressing lower fluorescent signal, were observed (Fig.  6A ). Many Mcm2-positive deposits were visible in the cytoplasm, in the proximity of the GV (Fig. 6A, arrow) . At the GVBD the clusters of insoluble Mcm2 were released into the cytoplasm. Initially they remained concentrated in the region occupied by the group of condensed chromatin (Fig. 6B) . Within next 15 min. they underwent dispersion in the cytoplasm (Fig. 6C, arrows) and 20 min. after GVBD they were no longer visible (Fig. 6D) . Cytoplasmic Mcm2-positive deposits, "dots", reappeared in maturing oocytes at about 3 h after GVBD (Fig. 6E, arrows) . Their number increased with the progression of maturation and at the metaphase of the first meiotic division (MI, 8-9 h after GVBD), numerous Mcm2-positive dots were dispersed randomly in the cytoplasm (Fig.6 F,G) . Similar distribution was maintained during anaphase and telophase of the first meiotic division and in MII arrested oocytes (Fig. 6 H-J) . The reappearance of Mcm2-positive deposits in the cytoplasm of maturing oocytes occurred independently of the protein synthesis (see Supplementary material). Cytoplasmic deposits (dots) were also observed in control oocytes, maturing in vivo (see Supplementary material). In oocytes stained without the primary antibody treatment such deposits or dots were never observed.
Localization of soluble and insoluble forms of Mcm2 during the first cell cycle of the parthenogenetic embryo
To know whether Mcm2 protein appears in embryonic cells like in somatic cells, we have followed its distribution in the female A'' 288 Swiech et al. protein, were present in the cytoplasm of non-extracted onecell embryos at G1 (Fig. 7A', arrow) . The overall, diffused fluorescent signal in the cytoplasm was slightly higher in embryos at G2 and such dots of insoluble, cytoplasmic Mcm2 were not visible (Fig. 8A') .
The pattern of the distribution of insoluble form of Mcm2 in the pronuclei varied depending on the phase of the cell cycle. In G1 and S pronuclei (5 h a.a. and 7 h a.a., respectively) the spots of insoluble Mcm2 protein were distributed within the whole nucleus (Fig. 7 B' ,C'). In contrast, in G2 female pronucleus the insoluble form of Mcm2 protein almost disappeared ( Fig. 8 B-B" ; signal of replication only in the 2 nd polar body).
The cytoplasmic dots, probably representing the insoluble, cytoplasmic form of Mcm2, were found also in one-cell embryos submitted to extraction procedure. Their number, size and intensity of staining diminished during the progression of the cell cycle. The largest and most numerous dots were observed in G1 embryo (Fig. 7B') , in S phase they were smaller and less numerous (Fig. 7C') and finally, in G2 embryo they were scarce (Fig. 8B') .
Discussion
In the present work we demonstrated the presence and the localization of three proteins of MCM family, Mcm2, 6 and 7 in the mouse ovarian oocytes. We showed that two of them, Mcm2 and Mcm7, appeared in two forms: the insoluble (detergentresistant) and soluble (detergent-sensitive) while the Mcm6 was detected only in the soluble form. The soluble Mcm proteins were uniformly distributed in the nuclei of resting oocytes, obtained from 2-3 days old females, as well as in the nuclei of growing and fully-grown oocytes. Insoluble Mcm2 and Mcm7 proteins, organized into granules or patches, were present in the nuclei of resting, growing and fully-grown NSN oocytes. The distribution of insoluble Mcm2 and Mcm7 proteins changed during the oocyte growth with the most dramatic changes occurring in the nuclei of fully-grown oocytes during the transition from the NSN to SN type of chromatin configuration. Tracing further behavior of insoluble Mcm2 we have shown also that this protein was gradually eliminated from the germinal vesicle of SN oocytes preparing for maturation and reappeared 3 h after GVBD in the form of cytoplasmic deposits (dots) that were next detected until the end of meiotic maturation and persisted in parthenogenetic one-cell embryo. In the first embryonic cell cycle, the insoluble Mcm2 protein was detected in G1 and was still present in S-phase pronuclei. In G2 embryos the insoluble form of Mcm2 disappeared from the pronuclei, while soluble Mcm2 was present in the pronuclei during the whole cell cycle. Such protein behavior was described previously for Mcm2 (Todorov et al., 1995; Dimitrova et al., 1999 , Prasanth et al., 2004 and other proteins of MCM family, such 
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as Mcm3 , Prasanth et al., 2004 and Mcm7 (Dimitrova and Berezney, 2002) , in proliferating mammalian somatic cells.
Progression of the first cell cycle of the mouse embryo and particularly the entering of the S phase, require that all factors necessary for chromatin licensing should be synthesized and stored in the oocyte during oogenesis. On the other hand, mouse ovarian oocyte, remains for weeks or months arrested in the prophase of the first meiotic division and thus requires an efficient mechanism that prevents DNA replication. This is probably why the ovarian oocytes lack of certain components of pre-RC complexes such as the Cdc6 protein, which is involved in the loading of the MCM proteins on to chromatin. Cdc6 protein is absent in the nuclei of fully-grown oocytes of Drosophila, Xenopus and mouse and is not synthesized before the initiation of maturation (Lemaître et al., 2002; 2004; Whitmire et al., 2002 , Anger et al., 2005 . In contrast, another component of pre-RC complex, the Mcm2 protein, was shown to be stored in the nuclei of fully-grown mouse oocytes (Lemaître et al., 2004) . The method applied by these authors allowed the visualization of total Mcm2 protein (without discrimination between soluble and insoluble form). In the present study we showed that not only the Mcm2, but also Mcm6 and 7 are present during mouse oogenesis and that Mcm2 and Mcm7 are accumulated in the oocyte also in the insoluble form. The role of these insoluble proteins is intriguing. The oocyte chromatin is in the unlicensed state, as is the chromatin of G2 somatic cell. Logically the insoluble proteins of the MCM family (generally engaged in DNA replication) should be absent. However, there are reports demonstrating that MCMs may have additional functions including chromatin remodeling, response to DNA damage and regulation of transcription (reviews: Bailis and Forsburg, 2004; Forsburg, 2004) . MCM proteins were shown to be the components of polymerase II transcriptional complexes that were isolated as high-molecular-weight holoenzyme units from Xenopus oocytes and HeLa cells (Yankulov et al., 1999) . Antibodies to Mcm2 inhibited transcription in Xenopus oocytes (Yankulov et al., 1999) . The insoluble form of Mcm2 and/or Mcm7 existing in mouse oocytes might therefore be a component of large enzyme machinery engaged in transcription.
RNA synthesis in the mouse oocytes is initiated soon after the birth of the female, continues during the entire period of oocyte growth and proceeds in the fully-grown NSN oocytes (review: Bachvarova, 1985; Bouniol-Baly et al., 1999) . Silencing of transcriptional activity appears concomitantly with the condensation of chromatin and its accumulation around the nucleolus during the transition to SN type oocyte (Bouniol-Baly et al., 1999) , two events that are probably controlled by different mechanisms (Burns et al., 2003 , De La Fuente et al., 2004 . During this transition, the Mcm2-and Mcm7-positive structures were reorganized and finally removed from the nucleus. Moreover, we have found that inhibition of RNA synthesis in oocytes obtained from 12-days old females, resulted in the condensation of chromatin and reorganization of insoluble form of Mcm2 and Mcm7 . Formation of large aggregates, occurring concomitantly with transcriptional silencing and condensation of chromatin (either physiological in fully-grown SN oocytes, or induced by α-amanitin treatment of oocytes obtained from 12-days old mouse females), was previously observed in the case of splicing factor SC-35 (Borsuk et al., 1996) . We can not exclude that such rearrangement of Mcm-positive structures occurs via a passive movement with condensing chromatin, having no relation to silencing of the transcription.
The DNA digestion with DNase I revealed that granules or aggregates of insoluble Mcm2 observed in fully-grown oocytes were associated with the chromatin. In somatic cells this protein is bound to the chromatin only when the other proteins of the pre-RC complex are already present in there. It has been proved that Cdc6 protein plays a crucial role in this process (Madine et al.,2000; Lei and Tye, 2001; Sun et al., 2000) . For the moment it is difficult to say how is the Mcm2 protein bound to the chromatin in fully-grown mouse oocytes, specially in the light of results presented by Lemaître et al. (2004) , who have shown that Cdc6 protein is absent in the germinal vesicle of fully-grown mouse oocytes.
In SN oocytes preparing for maturation, Mcm2 and Mcm7 proteins shifted from the insoluble (hypophosphorylated) to soluble (hyperphosphorylated) form and the soluble proteins dominated in the nucleus. These changes correlate well with phosphorylation changes in oocytes initiating maturation (Choi et al., 1991) . Prevalence of soluble MCMs is typical for G2 nucleus of somatic cell (Todorov et al., 1995; Dimitrova et al., 1999; Prasanth et al., 2004) and for G2 pronucleus of one-cell parthenogenetic mouse embryo (this work). In the case of mouse oocytes, only the most advanced stage of ovarian oocytes gain the feature typical for G2.
In the present studies we also showed the presence of Mcm2-positive deposits (dots) in the cytoplasm. They appeared for the first time in oocytes maturing in vitro, just before and soon after GVBD. Then they disappeared and reappeared at prometaphase I independently of the protein synthesis de novo. Again, changes in the phosphorylation may play a role in these modifications. The Mcm2-positive dots were also observed in the cytoplasm of oocytes maturing in vivo as well as 290 Swiech et al. during the first cell cycle of parthenogenetic embryo. Their distribution was in most cases random except the oocytes at prometaphase I where dots seemed to concentrate in the region around the metaphase plate. This observation contradicts the data presented by Lemaître et al. (2004) Figs. S1 and S2) .
During the first cell cycle of parthenogenetic embryo the cytoplasmic deposits of Mcm2 were most numerous at G1 and almost disappeared at G2, at the time when the insoluble form of nuclear Mcm2 shifted to soluble one. Whether Mcm2-positive dots constitute the cytoplasmic store of replication-related protein remains to be established. Such cytoplasmic deposits of proteins of MCM family have never been described in somatic cells, although the necessity of the formation of cytoplasmic aggregates of the MCM proteins in Saccharomyces pombe was suggested by Pasion and Forsburg (1999) . It is worthy to recall that multiple cytoplasmic deposits of Cdc6 protein were detected in immunostained HeLa and CHO cells (Alexandrow et al., 2004) .
Although, at present, no particular function can be attributed to accumulation of Mcm proteins in the nuclei of mouse ovarian oocytes and to Mcm2 deposits in the cytoplasm, we hope that our observations open a new path for further exploration of the subject.
Materials and Methods
Ethical approval for presented study was obtained from the Local Ethic Committee No.1 in Warsaw (Poland). Oocytes were obtained from F1(C57BL/10 x CBA/H) and F1(C57BL/6 x CBA/H) females and from F1 females of reverse crosses. The chemicals were purchased from Sigma-Aldrich Co. (Germany) unless stated otherwise.
Collection of the oocytes
Early oocytes
Non-growing oocytes (primordial or resting, diameter 12-14 µm) were obtained from 2-3-days-old newborns. Oocytes just initiating growth (diameter ca 20 µm) were recovered from 5-days-old females. The ovaries were freed of adhering tissues in M2 medium (Fulton and Whittingham, 1978) and incubated for 15 min at 37 o C in phosphate buffered saline (PBS, Biomed, Poland) containing testicular hyaluronidase (type I-S), collagenase (type I) and egg white lysozyme (International Enzymes, UK) (0.5 mg/ml of each) according to the method of Mangia and Epstein (1975) . Isolated oocytes were cultured in M2 medium, under paraffin oil, at 37 o C, in 5% CO 2 in the air. To make further manipulations of early oocytes easier, they were aggregated with fully-grown "carrier" oocytes. After few minutes of preincubation in phytohemagglutinin (300 µg/ml in BSA-free M2 medium) in an agarcoated watch glass, several early oocytes were aggregated with a single carrier oocyte. The aggregates were washed in M2 medium and then processed for cell extraction and/or fixation for immunostaining (see below).
Growing oocytes
A population of growing oocytes (diameter 50-60 µm) was obtained by puncturing the ovaries of sexually immature females (10 -12 days postpartum) in M2 medium. The zonae pellucidae were removed with 0.5% Pronase in Ringer's solution. Zona-free growing oocytes were processed for cell extraction and/or fixation for immunostainig.
Fully-grown oocytes
Adult females were injected intraperitoneally with pregnant mare's serogonadotrophin (PMSG, 10 IU; Intervet International B.V., Boxmeer, Holland) to stimulate the growth of the follicles and 49-52 h later they were sacrificed by cervical dislocation. Oocytes were obtained by puncturing the largest follicles of excised ovaries in M2 medium supplemented with dibutyryl cyclic AMP (dbcAMP, 150 µg/ml) to prevent spontaneous maturation. Zonae pellucidae were removed with 0.5% Pronase in Ringer's solution. Zona-free oocytes were washed in M2+dbcAMP, incubated for 30 minutes in the same medium and processed for cell extraction and/or fixation for immunostaining.
Meiotic maturation of fully-grown oocytes
Fully-grown oocytes were obtained from adult females in M2+dbcAMP as it was described above. They were classified into NSN and SN oocytes under vital conditions according to the method described by Debey et al. (1989) . Briefly, oocytes were incubated for 30 min. in M2+dbcAMP supplemented with 2 ng/ml of Hoechst dye (bisbenzimid H 33342, Riedelde-Häen, Netherlands). Afterwards their chromatin configuration was analyzed with the help of fluorescent microscope (Axiovert 135, Carl Zeiss Jena, Jena, Germany). The UV radiation was reduced to nonharmful level using the neutral attenuation filter (x0.03, Carl Zeiss Jena). Images were recorded with the CCD camera (Pixelfly, PCO, Germany). Only oocytes classified as SN type were used for in vitro maturation. To indicate precisely the moment of germinal vesicle breakdown (GVBD) the oocytes were microinjected with dextran conjugated with FITC (MW 70 000, Molecular Probes, Eugene, USA) using the method of . Intracytoplasmic microinjections were performed with the help of Eppendorf microinjector (type 5242, Eppendorf, Germany) connected with micromanipulator Leitz (Leitz, Germany). The solution of dextran was prepared immediately before microinjection from the stock solution (10 mg/ml of distilled water) diluted to final concentration of 2 mg/ml in 2 mM Pipes buffer (pH 7.4) containing 0.14 M KCl. Afterwards oocytes were washed in M2 medium to remove dbcAMP and cultured in vitro in this medium. They were observed under fluorescent microscope until initiation of nuclear envelope breakdown signalized by entrance of dextran into germinal vesicle . Some of these oocytes were immediately submitted to extraction procedure. The other were cultured in vitro and subjected to cell extraction at the moment of GVBD, 15 -20 min. after GVBD and 1, 3, 5, 6, 8-9, 10-11 and 12 h after GVBD. Their zonae pellucidae were removed with acidic Tyrode's solution (pH 2.5) 30 min. before extraction. Oocytes maturing in vivo served as a control group (see Supplementary Material at the end of this article).
Parthenogenetic one-cell eggs
Ovulated (metaphase II-arrested) oocytes were obtained from adult female mice, induced to ovulate with PMSG and human chorionic gonadotrophin (hCG, 10 IU; Intervet International B.V., Boxmeer, Holland). Chorionic gonadotrophin was administered 48 to 54h after injection of PMSG. Oocytes were harvested 17 1 / 2 -18 h after hCG injection, treated with hyaluronidase (500 µg/ml in Ca 2+ /Mg 2+ -free PBS) to remove cumulus cells and washed in M2 medium. They were activated parthenogenetically 18-18 1 / 2 h after hCG injection, by exposure to 8% ethanol in M2 for 8 min (Cuthbertson et al., 1981; Cuthbertson, 1983) . Activated eggs (judged by the presence of the 2 nd polar body and female pronucleus), were cultured in M2 medium until they have reached the desired phase of the first cell cycle. Some eggs were injected into the cytoplasm with digoxigenin-11-dUTP (dig-11-dUTP; 1 mM solution-undiluted commercial product, Roche Diagnostics GmbH, Germany), using an Eppendorf microinjector. Microinjections were performed 4, 7 and 16 h after activation. Injected eggs were cultured in M2 for 30 to 60 minutes. After removing zonae pellucidae, injected and non-injected eggs were submitted to cell extraction and/or fixation for immunostaining.
Inhibition of transcription in growing oocytes by α α α α α-amanitin treatment Growing oocytes obtained from females at 10-12 days postpartum were placed in drops of Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Eugene, USA) supplemented with 10% FBS, antibiotics and with 4.5 mg/ml of glucose, containing α-amanitin (10 µg/ml) and cultured under standard conditions. Control group of oocytes was cultured for the same period of time in DMEM medium without α-amanitin. After 20 h of culture the zonae pellucidae of oocytes from both groups were removed with Pronase. Zona-free oocytes were then incubated for 30 minutes in medium with or without α-amanitin and processed for cell extraction and fixation for immunostaining.
Detection of transcription
Transcription in growing oocytes cultured in the presence of α-amanitin and in control oocytes was examined according to the method of Bouniol et al. (1995) . After 19 h of culture oocytes were microinjected with 1-2 pl of BrUTP (100 mM solution in 2 mM Pipes buffer with 140 mM KCl, pH 7.4), cultured for the next 30 minutes and fixed for immunocytochemistry. BrU incorporation was detected using mouse monoclonal anti-BrdU antibody (IgG) as the primary antibody and FITC-conjugated goat anti-mouse IgG (H+L) secondary antibody (Caltag Laboratories, Burlingame, CA, USA). To visualize the chromatin the oocytes were stained with chromomycin A3 (10 µg/ml PBS).
Cell extraction and fixation
To visualize insoluble form of Mcm2, 6 and 7 proteins, the oocytes were extracted using the method of Sun et al. (2000) . After washing with ice-cold Ca +2 /Mg +2 -free PBS (PBS A ) and ice-cold cytoskeleton (CSK) buffer (10 mM Pipes, pH 7.0, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 ) oocytes were treated with CSK buffer containing 0.5% Triton X-100, 0.5 mM PMSF, 10 µg/ml of both leupeptin and aprotinin, for 3 min on ice. In some of the fully-grown oocytes DNA was digested with DNase I. For this purpose DNase I (100 µg/ml) has been added to the extraction buffer and the oocytes were treated with this buffer for 10 -30 min. at 37ºC. Control oocytes were submitted to the same procedure in DNase I free extraction buffer. Immediately after extraction oocytes were fixed in 2% paraformaldehyde (PFA) in PBS A for 20 min and blocked for at least 60 min in 2% BSA (bovine serum albumin, fraction V) in PBS A before immunostaining.
To demonstrate the total (soluble and insoluble) Mcm2, 6 and 7 proteins, the oocytes not submitted to cell extraction were fixed in 2% PFA for 20 min and after washing in PBS A they were permeabilized in 0.2% Triton X-100 in PBS A and blocked for at least 60 min in 2% BSA in PBS A before immunostaining.
Immunostaining
The Mcm2 and 6 proteins were detected using, respectively, goat polyclonal anti- primary antibodies (Santa Cruz Biotechnology Inc., USA) and FITCconjugated donkey anti-goat IgG (H+L) secondary antibody (Jackson Immunoresearch Laboratories, Inc., USA). The Mcm7 protein was detected using mouse monoclonal anti-Mcm7 primary antibody (sc-9966, Santa Cruz Biotechnology Inc., USA) and TRITC-conjugated goat antimouse IgG + IgM (H+L) secondary antibody (Jackson Immunoresearch Laboratories, Inc., USA). To visualize the chromatin, oocytes were stained with Hoechst 33342 (bisbenzimid H 33342, 2-4 µg/ml PBS A , Riedel-de-Häen, Netherlands) or chromomycin A3 (10 µg/ml PBS). Specificity of the immunoreaction was checked on oocytes stained without the incubation with primary antibody.
Microscopy
Oocytes were mounted on poly-L-lysine-coated (10% solution in H 2 O) slides in the mounting medium -Citifluor (glycerol/PBS solution; Citifluor Ltd., London, U.K.). In some cases Vectashield with propidium iodide (Vector Laboratories, Inc., USA), was used instead of Citifluor. Preparations were analyzed using a confocal microscope (LSM 510, Carl Zeiss Jena, Germany) or an epifluorescence microscope (Axiovert 135; Carl Zeiss Jena, Germany), equipped with CCD camera (Pixelfly, PCO, Germany).
Control of the specificity of primary antibodies
The specificity of the primary antibodies was confirmed on the Western blots on protein lysats prepared from the ovaries obtained from sexually immature (13 days old) and sexually mature (2 months old) females and from ovulated oocytes (Supplementary material; Fig. S1 ). Additionally the same primary antibodies have been used for immunodetection of Mcm2, 6 and 7 in somatic cells (Supplementary material; Fig. S2 ).
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Control of specificity of primary antibodies
Western blotting
The specificity of primary antibodies was confirmed on the Western blots on protein lysats prepared by homogenization of the ovaries obtained from sexually immature (13 days old) or sexually mature (2 months old) females in ELB lyses buffer (0.1% NP-40, 160 mM NaCl, 50 mM HEPES, 50 mM EDTA). Four ovaries from immature females and two ovaries from mature female were used for preparing the protein lysats. These lysats contained the Mcm proteins present in oocytes and in the ovarian somatic cells. Additionally, the specificity of anti-Mcm2 antibody was analyzed on Western blot prepared from ovulated oocytes. Two hundred and fifty oocytes were washed in PBS A , collected in loading buffer (Laemmli, 1970) and boiled for 10 min. Three micrograms of the proteins were separated by 8% SDS-PAGE results showed that in non-synchronized cell culture the soluble form of Mcm2, -6 and -7 was present in the nuclei of interphase cells and in the cytoplasm of mitotic cells (Fig. 2S A',C'; arrows). The intensity of staining of some nuclei differed slightly (Fig. S2 A',C', arrowheads). This differences were much better visible in cells submitted to extraction procedure, in which only the insoluble form of analyzed proteins was detected ( Fig. S2 B' ,D',F').
In some cells the intensity of staining in the nuclei was similar to observed in non-extracted cells and additionally irregular patches of the protein were visible (Fig. S2 B' ,D',F'; arrows). In the other cells the number of patches and the staining of the background in the nucleus was lower (Fig. S2B' ; arrowhead) or was barely A B C D E F visible (Fig. S2F' ; arrowhead). Observed differences reflect changes in the association of the Mcm proteins with the chromatin taking place during the cell cycle as it was described earlier (Todorov, 1995; Dimitrova and Berezney, 2002) . Results presented above confirmed the specificity of primary antibodies used in the present work.
Protein synthesis is not required for the reappearance of cytoplasmic deposits of insoluble Mcm2 protein
To verify whether the reappearance of Mcm2-positive deposits in maturing oocytes depends on the protein synthesis de novo, oocytes classified as SN type were cultured in the continuous presence of protein synthesis inhibitor, cycloheximide (CHX, 10 mg/ml). GV-intact oocytes were cultured for 2 or 6 h in M2+dbcAMP supplemented with CHX. Then, the dbcAMP was washed out to induce meiotic maturation and the oocytes were cultured in M2 with CHX for up to 6 h. Oocytes not treated with CHX and cultured in standard conditions served as a control group. In GV-intact oocytes cultured in the presence of CHX, large aggregates of Mcm2 were no more observed. Instead of them, numerous small granules of the protein situated near the nucleolus and few Mcm2-positive dots in the cytoplasm were observed (Fig. S4 A,B) . In control, GV-intact oocytes, cultured for the same period of time in CHX-free medium, large aggregates of Mcm2 were also rarely visible. In most cases only 1 or 2 granules of the protein, larger than observed in CHX-treated oocytes and regular in shape were present in the nucleus. Sometimes few Mcm2-positive dots were observed in the cytoplasm (Fig. S4E, arrows) . After removing of dbcAMP, when oocytes underwent GVBD, in both control and CHX-treated oocytes, the Mcm2-positive deposits appeared in the cytoplasm. They disappeared about 20 -30 min. later and reappeared 3 -4 h after GVBD (Fig. S4 C,D -CHX treated and G,H -control oocytes). These results show that appearance of cytoplasmic Mcm2-positive dots in maturing oocytes does not depend of ongoing protein synthesis.
